DNAPrint Genomics, Inc.
DNAG · OTC
12/31/2006 | 12/31/2005 | 12/31/2004 | 12/31/2003 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | 0.02 | -0.00 |
| FCF Yield | -185.74% | -189.88% | -49.10% | -4.48% |
| EV / EBITDA | -1.12 | -0.52 | -3.26 | -6.75 |
| Quality | ||||
| ROIC | 0.00% | 0.00% | 0.00% | 0.00% |
| Gross Margin | 30.99% | 25.48% | 35.35% | 39.09% |
| Cash Conversion Ratio | 0.47 | 0.41 | 1.01 | 0.20 |
| Growth | ||||
| Revenue 3-Year CAGR | 45.76% | 21.59% | 62.07% | 266.72% |
| Free Cash Flow Growth | -65.53% | 2.41% | -147.50% | 2.76% |
| Safety | ||||
| Net Debt / EBITDA | -0.75 | 0.31 | 0.15 | -0.11 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 17.41 | 3.18 | 7.78 | 0.00 |
| Cash Conversion Cycle | -622.29 | -298.82 | -96.33 | -269.66 |